Distinguished in Chronic Obstructive Pulmonary Disease (COPD)

Olivier Le Rouzic

Lille, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Chronic Obstructive Pulmonary Disease (COPD)
Lille, FR 
OverviewLocationsClinical Research

Overview

Olivier Le Rouzic practices in Lille, France. Mr. Le Rouzic is rated as a Distinguished expert by MediFind in the treatment of Chronic Obstructive Pulmonary Disease (COPD). His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Periventricular Heterotopia, and Pneumonia.

His clinical research consists of co-authoring 65 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 40 articles and participated in 2 clinical trials in the study of Chronic Obstructive Pulmonary Disease (COPD).

Gender
Male

Locations

Lille, 59000, France
Other Locations
Roubaix, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation: a Double-blind, Randomized, Controlled Trial
Enrollment Status: Recruiting
Publish Date: January 26, 2024
Intervention Type: Drug
Study Drug: 5 days of Systemic Corticotherapy (Prednisone)
Study Phase: Phase 3
Impact of Air Pollution on Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in Haut de France. BePoPi Project.
Impact of Air Pollution on Chronic Obstructive Pulmonary Disease (COPD) Exacerbation in Haut de France. BePoPi Project.
Enrollment Status: Completed
Publish Date: September 13, 2023
Intervention Type: Other
Circulation of Pathogenic Fungi in the Domestic Environment: Clinical Impact of Mould and Pneumocystis Jirovecii Exposure on COPD Patients
Circulation of Pathogenic Fungi in the Domestic Environment: Clinical Impact of Mould and Pneumocystis Jirovecii Exposure on COPD Patients
Enrollment Status: Completed
Publish Date: December 22, 2017
View 2 Less Clinical Trial

65 Total Publications

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.
Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy.
Journal: Advances in therapy
Published: May 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Le Rouzic's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile